Global Trends in Key Modifiable Cardiovascular Risk Factors: A Joinpoint Analysis Across WHO Regions (1990-2022) [0.03%]
世界卫生组织各区域主要可改变心血管危险因素的全球趋势（1990-2022年）——基于Joinpoint模型的分析
Dion Candelaria,Tiffany Atkins,Tom Briffa et al.
Dion Candelaria et al.
Aim: To examine temporal trends and quantify changes in prevalence of major cardiovascular disease risk factors (hypertension, tobacco use, elevated cholesterol, diabetes mellitus, insufficient physical activity) across W...
Long-term exposure to bushfire-related fine particulate matter and coronary plaque burden in asymptomatic adults [0.03%]
长期暴露于山火相关的细颗粒物与无症状成年人的冠状动脉斑块负担之间的关系
Adam Wondmieneh Belay,Nicolas Borchers-Arriagada,Nitesh Nerlekar et al.
Adam Wondmieneh Belay et al.
Aims: This study assessed the association between long-term exposure to bushfire-related fine particulate matter (PM2.5) and coronary plaque volume and components in asymptomatic adults. ...
Does too much exercise damage the heart? A narrative review of the long-term cardiovascular effects of intense training [0.03%]
过度锻炼会损害心脏吗？一篇关于高强度训练长期心血管效应的叙述性评论
Alessandro Zorzi,Mark Abela,Vincent L Aengevaeren et al.
Alessandro Zorzi et al.
Long-term exposure to high-intensity endurance exercise induces significant physiological cardiovascular remodelling. However, recent evidence suggests that prolonged exercise in athletes, particularly those exposed to decades of intensive ...
Association of Cancer Incidence and Cancer-Related Mortality with Statin Therapy, Ezetimibe, and Statin-Ezetimibe Combination - A Systematic Review and Bayesian Network Meta-analysis of Randomized Controlled Trials [0.03%]
他汀、依折麦布以及他汀联合依折麦布治疗与癌症发病率和癌症相关死亡率的关联-随机对照试验的系统评价和贝叶斯网状meta分析
Natasha Ghalib,Mahima Tyagi,Salim Virani et al.
Natasha Ghalib et al.
Background: Statins and ezetimibe are widely used and safe lipid-lowering therapies for the prevention of atherosclerotic cardiovascular disease. However, concerns persist, especially among the lay public, about the possi...
Correction to: Development and validation of the INFLammation in Acute Myocardial diseases risk Estimation for Myocardial Infarction (INFLAME-MI) score [0.03%]
急性心肌缺血炎症评分(INFLAME-MI)的制定和验证( Corrections )
Published Erratum
European journal of preventive cardiology. 2026 Jul 28:zwag389. DOI:10.1093/eurjpc/zwag389 2026
Reconsidering Obesity After Myocardial Infarction: Is the Paradox Finally Resolving? [0.03%]
心肌梗死后重新考虑肥胖：悖论终于消解了吗？
Shaun Khanna,Nitesh Nerlekar,Clare Arnott
Shaun Khanna
Navigating Clinical Likelihood and Cardiovascular Risk over a Lifetime Course of Coronary Artery Disease [0.03%]
冠心病终身发病风险和心血管事件风险的变迁规律研究
Simon Winther,Laust D Rasmussen,Christiaan J M Vrints
Simon Winther
Longer-Term Efficacy and Safety of Zodasiran in Patients with Mixed Hyperlipidaemia [0.03%]
用于混合型高脂血症患者的Zodasiran的长期疗效和安全性
Robert S Rosenson,Daniel Gaudet,Christie M Ballantyne et al.
Robert S Rosenson et al.
Background: Mixed hyperlipidaemia, characterized by elevated cholesterol and triglyceride levels, is associated with increased risk of atherosclerotic cardiovascular disease (ASCVD). Angiopoietin-like protein 3 (ANGPTL3) ...